| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 紫芝烯酸C; Ganosinensic acid C | CFN95567 | 2231756-23-1 | C30H40O7 = 512.6 | 5mg | QQ客服：3257982914 |
| 缝籽嗪; Geissoschizine | CFN95566 | 439-66-7 | C21H24N2O3 = 352.4 | 5mg | QQ客服：2056216494 |
| Peltatoside 7-O-beta-glucopyranoside; Peltatoside 7-O-beta-glucopyranoside | CFN95565 | 813466-12-5 | C32H38O21 = 758.6 | 20mg | QQ客服：3257982914 |
| 3''-O-咖啡酰橙皮苷; 3''-O-Caffeoylhesperidin | CFN95564 | N/A | C37H40O18 = 772.7 | 5mg | QQ客服：215959384 |
| Octyl 3-(4-hydroxyphenyl)prop-2-enoate; Octyl 3-(4-hydroxyphenyl)prop-2-enoate | CFN95563 | N/A | C17H24O3 = 276.4 | 5mg | QQ客服：1457312923 |
| Taxezopidine H; Taxezopidine H | CFN95562 | 205440-23-9 | C35H44O9 = 608.7 | 5mg | QQ客服：1413575084 |
| 新化合物21; New compound 21 | CFN95560 | N/A | C30H42O7 = 514.7 | 5mg | QQ客服：2159513211 |
| 米林酸; Nomilinic acid | CFN95559 | 35930-20-2 | C28H36O10 = 532.6 | 5mg | QQ客服：215959384 |
| 3',3'''-二柚皮素; 3',3'''-Binaringenin | CFN95558 | 145399-99-1 | C30H22O10 = 542.5 | 5mg | QQ客服：3257982914 |
| 原儿茶酸4-O-beta-葡萄糖苷; Protocatechuic acid 4-O-beta-glucoside | CFN95557 | 7361-59-3 | C13H16O9 = 316.3 | 5mg | QQ客服：2159513211 |
| 鹿梨苷; Calleryanin | CFN95556 | 20300-53-2 | C13H18O8 = 302.3 | 5mg | QQ客服：1413575084 |
| 益智酮甲; Yakuchinone A | CFN95555 | 78954-23-1 | C20H24O3 = 312.4 | 10mg | QQ客服：1457312923 |
| 麻黄宁B; Mahuannin B | CFN95554 | 82796-37-0 | C30H24O10 = 544.5 | 5mg | QQ客服：215959384 |
| 麻黄宁G; Mahuannin G | CFN95553 | N/A | C30H22O10 = 542.5 | 5mg | QQ客服：2159513211 |
| Symplocoside; Symplocoside | CFN95552 | 76502-76-6 | C22H26O11 = 466.4 | 5mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)